Related references
Note: Only part of the references are listed.Evaluation of antileishmanial drugs activities in an ex vivo model of leishmaniasis
Myriam Janeth Salazar Terreros et al.
PARASITOLOGY INTERNATIONAL (2019)
Evaluating drug resistance in visceral leishmaniasis: the challenges
S. Hendrickx et al.
PARASITOLOGY (2018)
Impact of primary mouse macrophage cell types on Leishmania infection and in vitro drug susceptibility
M. Van den Kerkhof et al.
PARASITOLOGY RESEARCH (2018)
Phagocytosis of hemozoin by RAW 264.7 cells, but not THP-1 cells, promotes infection by Leishmania donovani with a nitric oxide-independent mechanism
Erika van den Bogaart et al.
PARASITOLOGY INTERNATIONAL (2017)
In vitro evaluation of traditionally used Surinamese medicinal plants for their potential anti-leishmanial efficacy
D. R. A. Mans et al.
JOURNAL OF ETHNOPHARMACOLOGY (2016)
In Vitro Infectivity Assessment by Drug Susceptibility Comparison of Recombinant Leishmania major Expressing Enhanced Green Fluorescent Protein or EGFP-Luciferase Fused Genes with Wild-Type Parasite
Somayeh Sadeghi et al.
KOREAN JOURNAL OF PARASITOLOGY (2015)
Intracellular amastigote replication may not be required for successful in vitro selection of miltefosine resistance in Leishmania infantum
S. Hendrickx et al.
PARASITOLOGY RESEARCH (2015)
Comparative Fitness of a Parent Leishmania donovani Clinical Isolate and Its Experimentally Derived Paromomycin-Resistant Strain
Sarah Hendrickx et al.
PLOS ONE (2015)
Development of an Ex Vivo Lymph Node Explant Model for Identification of Novel Molecules Active against Leishmania major
Alex G. Peniche et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Elucidation of Cellular Mechanisms Involved in Experimental Paromomycin Resistance in Leishmania donovani
Vasundhra Bhandari et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Increasing Failure of Miltefosine in the Treatment of Kala-azar in Nepal and the Potential Role of Parasite Drug Resistance, Reinfection, or Noncompliance
Suman Rijal et al.
CLINICAL INFECTIOUS DISEASES (2013)
High Content Analysis of Primary Macrophages Hosting Proliferating Leishmania Amastigotes: Application to Anti-leishmanial Drug Discovery
Nathalie Aulner et al.
PLOS NEGLECTED TROPICAL DISEASES (2013)
In vitro Antileishmanial Drug Susceptibility of Clinical Isolates from Patients with Indian Visceral Leishmaniasis-Status of Newly Introduced Drugs
Vijay Kumar Prajapati et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2012)
Mechanism of Amphotericin B Resistance in Clinical Isolates of Leishmania donovani
Bidyut Purkait et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
A comparison of two distinct murine macrophage gene expression profiles in response to Leishmania amazonensis infection
Christian M. Probst et al.
BMC MICROBIOLOGY (2012)
Genetic Markers for SSG Resistance in Leishmania donovani and SSG Treatment Failure in Visceral Leishmaniasis Patients of the Indian Subcontinent
Manu Vanaerschot et al.
JOURNAL OF INFECTIOUS DISEASES (2012)
Impact of Continuous Axenic Cultivation in Leishmania infantum Virulence
Diana Moreira et al.
PLOS NEGLECTED TROPICAL DISEASES (2012)
Leishmania donovani Develops Resistance to Drug Combinations
Raquel Garcia-Hernandez et al.
PLOS NEGLECTED TROPICAL DISEASES (2012)
Leishmania Resistance to Miltefosine Associated with Genetic Marker
Sandrine Cojean et al.
EMERGING INFECTIOUS DISEASES (2012)
Drug susceptibility of Leishmania infantum (syn. Leishmania chagasi) isolates from Brazilian HIV-positive and HIV-negative patients
Raquel Inocencio da Luz et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2011)
Identification of Small Molecule Lead Compounds for Visceral Leishmaniasis Using a Novel Ex Vivo Splenic Explant Model System
Yaneth Osorio et al.
PLOS NEGLECTED TROPICAL DISEASES (2011)
Amphotericin B inhibits entry of Leishmania donovani into primary macrophages
Yamuna Devi Paila et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
In vitro activity of anti-leishmanial drugs against Leishmania donovani is host cell dependent
Karin Seifert et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2010)
The Identification of Markers of Macrophage Differentiation in PMA-Stimulated THP-1 Cells and Monocyte-Derived Macrophages
Marc Daigneault et al.
PLOS ONE (2010)
Drug Resistance in Leishmaniasis
Jaya Chakravarty et al.
JOURNAL OF GLOBAL INFECTIOUS DISEASES (2010)
In Vitro Susceptibilities of Leishmania donovani Promastigote and Amastigote Stages to Antileishmanial Reference Drugs: Practical Relevance of Stage-Specific Differences
Marieke Vermeersch et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
In Vitro Sensitivity Testing of Leishmania Clinical Field Isolates: Preconditioning of Promastigotes Enhances Infectivity for Macrophage Host Cells
Raquel Inocencio da Luz et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Drug resistance in leishmaniasis
SL Croft et al.
CLINICAL MICROBIOLOGY REVIEWS (2006)
Infection of human mononuclear phagocytes and macrophage-like THP1 cells with Leishmania donovani results in modulation of expression of a subset of chemokines and a chemokine receptor
B Dasgupta et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2003)
Monitoring drug resistance in leishmaniasis
SL Croft
TROPICAL MEDICINE & INTERNATIONAL HEALTH (2001)
Share Paper
